$NIC
NICOLET BANKSHARES INC Stock $nic

$nic Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000117485021000029 Filed on April 30, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$36.88M	$37.00M
YoY Change	-0.34%	11.59%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.700M	$2.200M
YoY Change	22.73%	100.0%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$3.235M	$5.740M
YoY Change	-43.64%	0.99%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$24.19M	$13.99M
YoY Change	72.83%	2.13%
Income Tax	$5.947M	$3.321M
% Of Pretax Income	24.59%	23.73%
Net Earnings	$18.24M	$10.56M
YoY Change	72.8%	2.81%
Net Earnings / Revenue	49.46%	28.52%
Basic Earnings Per Share	$1.82	$1.00
Diluted Earnings Per Share	$1.75	$0.98
COMMON SHARES
Basic Shares Outstanding	9.998M shares	10.52M shares
Diluted Shares Outstanding	10.40M shares	10.80M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$735.9M	$242.0M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$59.41M	$60.28M
YoY Change	-1.43%	21.91%
Goodwill	$163.2M	$151.2M
YoY Change	7.91%	40.82%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$4.544B	$3.733B
YoY Change	21.73%	22.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$49.20M	$39.60M
YoY Change	24.24%	54.69%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$75.00M
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$49.20M	$114.6M
YoY Change	-57.07%	347.66%
LONG-TERM LIABILITIES
Long-Term Debt	$25.00M	$42.70M
YoY Change	-41.45%	1.18%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$25.00M	$42.70M
YoY Change	-41.45%	1.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$49.20M	$114.6M
Total Long-Term Liabilities	$25.00M	$42.70M
Total Liabilities	$3.994B	$3.221B
YoY Change	24.0%	21.93%
SHAREHOLDERS EQUITY
Retained Earnings	$271.2M	$203.4M
YoY Change	33.34%	31.53%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$550.0M	$511.0M
YoY Change
Total Liabilities & Shareholders Equity	$4.544B	$3.733B
YoY Change	21.73%	22.74%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$18.24M	$10.56M
YoY Change	72.8%	2.81%
Depreciation, Depletion And Amortization	$2.700M	$2.200M
YoY Change	22.73%	100.0%
Cash From Operating Activities	$38.21M	$12.17M
YoY Change	214.12%	18.14%
INVESTING ACTIVITIES
Capital Expenditures	$500.0K	$5.000M
YoY Change	-90.0%	108.33%
Acquisitions
YoY Change
Other Investing Activities	-$81.70M	-$92.20M
YoY Change	-11.39%	317.19%
Cash From Investing Activities	-$82.17M	-$97.20M
YoY Change	-15.47%	296.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$4.504M	$14.98M
YoY Change	-69.94%	170.73%
Debt Paid & Issued, Net	$10.00M	$5.000M
YoY Change	100.0%	7712.5%
Cash From Financing Activities	-$23.05M	$144.9M
YoY Change	-115.91%	-279.93%
NET CHANGE
Cash From Operating Activities	$38.21M	$12.17M
Cash From Investing Activities	-$82.17M	-$97.20M
Cash From Financing Activities	-$23.05M	$144.9M
Net Change In Cash	-$67.01M	$59.90M
YoY Change	-211.86%	-163.21%
FREE CASH FLOW
Cash From Operating Activities	$38.21M	$12.17M
Capital Expenditures	$500.0K	$5.000M
Free Cash Flow	$37.71M	$7.165M
YoY Change	426.35%	-9.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001174850
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-37700
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	NICOLET BANKSHARES, INC
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WI
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-0871001
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	111 North Washington Street
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Green Bay,
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	WI
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	54301
CY2021Q1	dei	City Area Code CityAreaCode	(920)
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	430-1400
CY2021Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2021Q1	dei	Trading Symbol TradingSymbol	NCBS
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9956521	shares
CY2021Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	61295000	USD
CY2020Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	88460000	USD
CY2021Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	674559000	USD
CY2020Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	714399000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	735854000	USD
CY2021Q1	ncbs	Time Deposit In Other Banks TimeDepositInOtherBanks	27296000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	802859000	USD
CY2020Q4	ncbs	Time Deposit In Other Banks TimeDepositInOtherBanks	29521000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	558229000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	539337000	USD
CY2021Q1	us-gaap	Other Investments OtherInvestments	28248000	USD
CY2020Q4	us-gaap	Other Investments OtherInvestments	27619000	USD
CY2021Q1	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	16883000	USD
CY2020Q4	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	21450000	USD
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	2846351000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2789101000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	32626000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	32173000	USD
CY2021Q1	us-gaap	Notes Receivable Net NotesReceivableNet	2813725000	USD
CY2020Q4	us-gaap	Notes Receivable Net NotesReceivableNet	2756928000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59413000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59944000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	83788000	USD
CY2020Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	83262000	USD
CY2021Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	174501000	USD
CY2020Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	175353000	USD
CY2021Q1	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	45867000	USD
CY2020Q4	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	55516000	USD
CY2021Q1	us-gaap	Assets Assets	4543804000	USD
CY2020Q4	us-gaap	Assets Assets	4551789000	USD
CY2021Q1	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	1216477000	USD
CY2020Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	1212787000	USD
CY2021Q1	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	2684117000	USD
CY2020Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	2697612000	USD
CY2021Q1	us-gaap	Deposits Deposits	3900594000	USD
CY2020Q4	us-gaap	Deposits Deposits	3910399000	USD
CY2021Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	43988000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	53869000	USD
CY2021Q1	us-gaap	Other Liabilities OtherLiabilities	49176000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	48332000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	3993758000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	4012600000	USD
CY2021Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	100000	USD
CY2020Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	100000	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	271388000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	273390000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	271191000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	252952000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7367000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	12747000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	550046000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	539189000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4543804000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4551789000	USD
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9987897	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10011342	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10002322	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10030267	shares
CY2021Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	33862000	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	33778000	USD
CY2021Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	1814000	USD
CY2020Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	2072000	USD
CY2021Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	545000	USD
CY2020Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	491000	USD
CY2021Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	655000	USD
CY2020Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	662000	USD
CY2021Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	36876000	USD
CY2020Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	37003000	USD
CY2021Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	2922000	USD
CY2020Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	4957000	USD
CY2021Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	0	USD
CY2020Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	27000	USD
CY2021Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	313000	USD
CY2020Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	756000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	3235000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	5740000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	33641000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	31263000	USD
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	500000	USD
CY2020Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3000000	USD
CY2021Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	33141000	USD
CY2020Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	28263000	USD
CY2021Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	7230000	USD
CY2020Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	2327000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	527000	USD
CY2020Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	703000	USD
CY2021Q1	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	711000	USD
CY2020Q1	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-654000	USD
CY2021Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	1072000	USD
CY2020Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	521000	USD
CY2021Q1	us-gaap	Noninterest Income NoninterestIncome	17126000	USD
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	9585000	USD
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	15116000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	13323000	USD
CY2021Q1	ncbs	Occupancy Equipment And Office Expense OccupancyEquipmentAndOfficeExpense	4137000	USD
CY2020Q1	ncbs	Occupancy Equipment And Office Expense OccupancyEquipmentAndOfficeExpense	4204000	USD
CY2021Q1	us-gaap	Business Development BusinessDevelopment	989000	USD
CY2020Q1	us-gaap	Business Development BusinessDevelopment	1359000	USD
CY2021Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	2658000	USD
CY2020Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	2563000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	852000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	993000	USD
CY2021Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	595000	USD
CY2020Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	0	USD
CY2021Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1734000	USD
CY2020Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1412000	USD
CY2021Q1	us-gaap	Noninterest Expense NoninterestExpense	26081000	USD
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	23854000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	24186000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	13994000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5947000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3321000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	18239000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	10673000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	118000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	18239000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	10555000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.82
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.00
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.75
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.98
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9997634	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10515778	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10403309	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10800636	shares
CY2021Q1	us-gaap	Profit Loss ProfitLoss	18239000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	10673000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-7369000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	4329000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-1989000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1168000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5380000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3161000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	12859000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	13834000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	539189000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	18239000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5380000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1341000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	1161000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	121000	USD
CY2021Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4625000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	550046000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	516990000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	10673000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3161000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1299000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	851000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	215000	USD
CY2020Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	15197000	USD
CY2020Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	77000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	511740000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	18239000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	10673000	USD
CY2021Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	2719000	USD
CY2020Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	2156000	USD
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	500000	USD
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	3000000	USD
CY2021Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	527000	USD
CY2020Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	525000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1341000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1299000	USD
CY2021Q1	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	711000	USD
CY2020Q1	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-654000	USD
CY2021Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	7255000	USD
CY2020Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	3017000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	222406000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	103950000	USD
CY2021Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	211701000	USD
CY2020Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	102715000	USD
CY2021Q1	ncbs	Increase Decrease In Accrued Interest Receivable And Other Assets IncreaseDecreaseInAccruedInterestReceivableAndOtherAssets	-9719000	USD
CY2020Q1	ncbs	Increase Decrease In Accrued Interest Receivable And Other Assets IncreaseDecreaseInAccruedInterestReceivableAndOtherAssets	5567000	USD
CY2021Q1	ncbs	Increase Decrease In Interest Payable And Other Liabilities IncreaseDecreaseInInterestPayableAndOtherLiabilities	-3483000	USD
CY2020Q1	ncbs	Increase Decrease In Interest Payable And Other Liabilities IncreaseDecreaseInInterestPayableAndOtherLiabilities	-2257000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	38213000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12165000	USD
CY2021Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	57003000	USD
CY2020Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	32238000	USD
CY2021Q1	ncbs	Increase Decrease In Certificates Of Deposit In Other Banks IncreaseDecreaseInCertificatesOfDepositInOtherBanks	-2225000	USD
CY2020Q1	ncbs	Increase Decrease In Certificates Of Deposit In Other Banks IncreaseDecreaseInCertificatesOfDepositInOtherBanks	-501000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	48402000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	74759000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	21215000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	17931000	USD
CY2021Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	89000	USD
CY2020Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	3673000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	81000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	0	USD
CY2021Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	485000	USD
CY2020Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4961000	USD
CY2021Q1	ncbs	Payments For Proceeds From Other Real Estate And Other Assets PaymentsForProceedsFromOtherRealEstateAndOtherAssets	-293000	USD
CY2020Q1	ncbs	Payments For Proceeds From Other Real Estate And Other Assets PaymentsForProceedsFromOtherRealEstateAndOtherAssets	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-82165000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-97199000	USD
CY2021Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-9710000	USD
CY2020Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	69143000	USD
CY2021Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2020Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	75000000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	20000000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	10000000	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5000000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4625000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	15197000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	121000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	215000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1161000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	851000	USD
CY2021Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2020Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	77000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-23053000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	144935000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-67005000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	59901000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	802859000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	182059000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	735854000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	241960000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	3492000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	6077000	USD
CY2021Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2020Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2021Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	302000	USD
CY2020Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	0	USD
CY2021Q1	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions	1117000	USD
CY2020Q1	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions	559000	USD
CY2021Q1	ncbs	Pledged Assets Separately Reported Restricted Cash Pledged As Collateral PledgedAssetsSeparatelyReportedRestrictedCashPledgedAsCollateral	1900000	USD
CY2020Q1	ncbs	Pledged Assets Separately Reported Restricted Cash Pledged As Collateral PledgedAssetsSeparatelyReportedRestrictedCashPledgedAsCollateral	1900000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	18239000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	10555000	USD
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying disclosures. These estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future. Estimates are used in accounting for, among other items, the allowance for credit losses, valuation of loans in acquisition transactions, useful lives for depreciation and amortization, fair value of financial instruments, impairment calculations, valuation of deferred tax assets, uncertain income tax positions and contingencies. Estimates that are particularly susceptible to significant change for the Company include the determination of the allowance for credit losses, the determination and assessment of deferred tax assets and liabilities, and the valuation of loans acquired in acquisition transactions; therefore, these are critical accounting policies. Factors that may cause sensitivity to the aforementioned estimates include but are not limited to: external market factors such as market interest rates and employment rates, changes to operating policies and procedures, changes in applicable banking or tax regulations, and changes to deferred tax estimates. Actual results may ultimately differ from estimates, although management does not generally believe such differences would materially affect the consolidated financial statements in any individual reporting period presented.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes or developments with respect to the assumptions or methodologies that the Company uses when applying what management believes are critical accounting policies and developing critical accounting estimates as disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.</span></div>
CY2021Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the 2020 consolidated financial statements have been reclassified to conform to the 2021 presentation.</span></div>
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9998000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10516000	shares
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	405000	shares
CY2020Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	285000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10403000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10801000	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.82
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.00
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.75
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.98
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1300000	shares
CY2021Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	5607	shares
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1200000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1300000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	8500000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
CY2021Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	200000	USD
CY2020Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	300000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	548137000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	13407000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3315000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	558229000	USD
CY2021Q1	ncbs	Percentage Of Total Debt Securities Available For Sale PercentageOfTotalDebtSecuritiesAvailableForSale	1
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	521876000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	17550000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	89000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	539337000	USD
CY2020Q4	ncbs	Percentage Of Total Debt Securities Available For Sale PercentageOfTotalDebtSecuritiesAvailableForSale	1
CY2021Q1	us-gaap	Debt Securities Available For Sale Restricted DebtSecuritiesAvailableForSaleRestricted	145000000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Restricted DebtSecuritiesAvailableForSaleRestricted	146000000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	132050000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3311000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	331000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	4000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	132381000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	3315000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	152	Security
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	15793000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	82000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	492000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	7000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	16285000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	89000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	31	Security
CY2021Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	91706000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	92221000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	160270000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	165873000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	121235000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	120172000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	11878000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	13063000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	385089000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	391329000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	548137000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	558229000	USD
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	2846351000	USD
CY2021Q1	ncbs	Percentage Of Total Notes Receivable Gross PercentageOfTotalNotesReceivableGross	1
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2789101000	USD
CY2020Q4	ncbs	Percentage Of Total Notes Receivable Gross PercentageOfTotalNotesReceivableGross	1
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	32626000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	32173000	USD
CY2021Q1	us-gaap	Notes Receivable Net NotesReceivableNet	2813725000	USD
CY2020Q4	us-gaap	Notes Receivable Net NotesReceivableNet	2756928000	USD
CY2021Q1	ncbs	Percentage Of Allowance For Credit Losses To Loans PercentageOfAllowanceForCreditLossesToLoans	0.0115
CY2020Q4	ncbs	Percentage Of Allowance For Credit Losses To Loans PercentageOfAllowanceForCreditLossesToLoans	0.0115
CY2020Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	7000000	USD
CY2021Q1	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	7000000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	32173000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13972000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13972000	USD
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	500000	USD
CY2020Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3000000	USD
CY2020	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	10300000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	94000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	93000	USD
CY2020	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	1689000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	47000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	38000	USD
CY2020	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	305000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	47000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	55000	USD
CY2020	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	1384000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	32626000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	26202000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	32173000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	32173000	USD
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	500000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	94000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	47000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	47000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	32626000	USD
CY2021Q1	ncbs	Percentage Of Allowance For Credit Losses PercentageOfAllowanceForCreditLosses	1
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13972000	USD
CY2020	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	10300000	USD
CY2020	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	1689000	USD
CY2020	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	305000	USD
CY2020	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	1384000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	32173000	USD
CY2020	ncbs	Percentage Of Allowance For Credit Losses PercentageOfAllowanceForCreditLosses	1
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACL-Loans represents management’s estimate of expected credit losses in the Company’s loan portfolio at the balance sheet date. To assess the appropriateness of the ACL-Loans, an allocation methodology is applied by Nicolet which focuses on evaluation of qualitative and environmental factors, including but not limited to: (i) evaluation of facts and issues related to specific loans; (ii) management’s ongoing review and grading of the loan portfolio; (iii) consideration of historical loan loss and delinquency experience on each portfolio segment; (iv) trends in past due and nonperforming loans; (v) the risk characteristics of the various loan segments; (vi) changes in the size and character of the loan portfolio; (vii) concentrations of loans to specific borrowers or industries; (viii) existing economic conditions; (ix) the fair value of underlying collateral; and (x) other qualitative and quantitative factors which could affect expected credit losses. Assessing these numerous factors involves significant judgment.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management allocates the ACL-Loans by pools of risk within each loan portfolio segment. The allocation methodology consists of the following components. First, a specific reserve is established for individually evaluated credit-deteriorated loans, which management defines as nonaccrual credit relationships over $250,000, collateral dependent loans, and other loans with evidence of credit deterioration. The specific reserve in the ACL-Loans for these credit deteriorated loans is equal to the aggregate collateral or discounted cash flow shortfall. Management allocates the ACL-Loans with historical loss rates by loan </span></div>segment. The loss factors are measured on a quarterly basis and applied to each loan segment based on current loan balances and projected for their expected remaining life. Next, management allocates the ACL-Loans using the qualitative factors mentioned above. Consideration is given to those current qualitative or environmental factors that are likely to cause estimated credit losses as of the evaluation date to differ from the historical loss experience of each loan segment. Lastly, management considers reasonable and supportable forecasts to assess the collectability of future cash flows.
CY2021Q1	ncbs	Material Loans Criteria For Acl Loans Adequacy Calculation MaterialLoansCriteriaForACLLoansAdequacyCalculation	250000	USD
CY2021Q1	ncbs	Collateral Dependent Financing Receivable Unpaid Principal Balance CollateralDependentFinancingReceivableUnpaidPrincipalBalance	9356000	USD
CY2021Q1	ncbs	Collateral Dependent Financing Receivable With No Related Allowance CollateralDependentFinancingReceivableWithNoRelatedAllowance	6645000	USD
CY2021Q1	ncbs	Collateral Dependent Financing Receivable With Related Allowance CollateralDependentFinancingReceivableWithRelatedAllowance	2711000	USD
CY2021Q1	ncbs	Collateral Dependent Financing Receivable Related Allowance CollateralDependentFinancingReceivableRelatedAllowance	957000	USD
CY2020Q4	ncbs	Collateral Dependent Financing Receivable Unpaid Principal Balance CollateralDependentFinancingReceivableUnpaidPrincipalBalance	8877000	USD
CY2020Q4	ncbs	Collateral Dependent Financing Receivable With No Related Allowance CollateralDependentFinancingReceivableWithNoRelatedAllowance	7180000	USD
CY2020Q4	ncbs	Collateral Dependent Financing Receivable With Related Allowance CollateralDependentFinancingReceivableWithRelatedAllowance	1697000	USD
CY2020Q4	ncbs	Collateral Dependent Financing Receivable Related Allowance CollateralDependentFinancingReceivableRelatedAllowance	1244000	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	2835159000	USD
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	2846351000	USD
CY2021Q1	ncbs	Financing Receivable Recorded Investment Current Percentage Of Loan FinancingReceivableRecordedInvestmentCurrentPercentageOfLoan	0.996
CY2021Q1	ncbs	Percentage Of Loans By Past Due Status PercentageOfLoansByPastDueStatus	1.000
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	2778881000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2789101000	USD
CY2020Q4	ncbs	Financing Receivable Recorded Investment Current Percentage Of Loan FinancingReceivableRecordedInvestmentCurrentPercentageOfLoan	0.996
CY2020Q4	ncbs	Percentage Of Loans By Past Due Status PercentageOfLoansByPastDueStatus	1.000
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	8965000	USD
CY2021Q1	ncbs	Percentage Of Non Accrual Loan PercentageOfNonAccrualLoan	1
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	9455000	USD
CY2020Q4	ncbs	Percentage Of Non Accrual Loan PercentageOfNonAccrualLoan	1
CY2021Q1	us-gaap	Financing Receivable Nonaccrual Percent Past Due1 FinancingReceivableNonaccrualPercentPastDue1	0.003
CY2020Q4	us-gaap	Financing Receivable Nonaccrual Percent Past Due1 FinancingReceivableNonaccrualPercentPastDue1	0.004
CY2021Q1	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	292876000	USD
CY2021Q1	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	696475000	USD
CY2021Q1	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	374542000	USD
CY2021Q1	us-gaap	Financing Receivable Originated Three Years Before Latest Fiscal Year FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear	273389000	USD
CY2021Q1	us-gaap	Financing Receivable Originated Four Years Before Latest Fiscal Year FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear	251891000	USD
CY2021Q1	us-gaap	Financing Receivable Originated Five Or More Years Before Latest Fiscal Year FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear	620547000	USD
CY2021Q1	us-gaap	Financing Receivable Revolving FinancingReceivableRevolving	335374000	USD
CY2021Q1	us-gaap	Financing Receivable Revolving Converted To Term Loan FinancingReceivableRevolvingConvertedToTermLoan	1257000	USD
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	2846351000	USD
CY2020Q4	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	800139000	USD
CY2020Q4	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	400410000	USD
CY2020Q4	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	299024000	USD
CY2020Q4	us-gaap	Financing Receivable Originated Three Years Before Latest Fiscal Year FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear	270810000	USD
CY2020Q4	us-gaap	Financing Receivable Originated Four Years Before Latest Fiscal Year FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear	153024000	USD
CY2020Q4	us-gaap	Financing Receivable Originated Five Or More Years Before Latest Fiscal Year FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear	519961000	USD
CY2020Q4	us-gaap	Financing Receivable Revolving FinancingReceivableRevolving	344080000	USD
CY2020Q4	us-gaap	Financing Receivable Revolving Converted To Term Loan FinancingReceivableRevolvingConvertedToTermLoan	1653000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2789101000	USD
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	2846351000	USD
CY2021Q1	ncbs	Percentage Of Loans By Past Due Status PercentageOfLoansByPastDueStatus	1.000
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2789101000	USD
CY2020Q4	ncbs	Percentage Of Loans By Past Due Status PercentageOfLoansByPastDueStatus	1.000
CY2021Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	8	Loan
CY2021Q1	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	5100000	USD
CY2021Q1	ncbs	Financing Receivable Nonaccrual Troubled Debt Restructuring Postmodification FinancingReceivableNonaccrualTroubledDebtRestructuringPostmodification	3000000.0	USD
CY2021Q1	ncbs	Financing Receivable Performing Troubled Debt Restructuring Postmodification FinancingReceivablePerformingTroubledDebtRestructuringPostmodification	2100000	USD
CY2021Q1	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	5500000	USD
CY2020	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	11	Loan
CY2020	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	5500000	USD
CY2020	ncbs	Financing Receivable Nonaccrual Troubled Debt Restructuring Postmodification FinancingReceivableNonaccrualTroubledDebtRestructuringPostmodification	3400000	USD
CY2020	ncbs	Financing Receivable Performing Troubled Debt Restructuring Postmodification FinancingReceivablePerformingTroubledDebtRestructuringPostmodification	2100000	USD
CY2020	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	6500000	USD
CY2021Q1	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0	Loan
CY2021Q1	us-gaap	Goodwill Goodwill	163151000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	163151000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11350000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12202000	USD
CY2021Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	174501000	USD
CY2020Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	175353000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	163151000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	151198000	USD
CY2021Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2021Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	11953000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	163151000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	163151000	USD
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	43988000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	53869000	USD
CY2021Q1	ncbs	Trust Preferred Securities Qualify As Tier1 Capital TrustPreferredSecuritiesQualifyAsTier1Capital	24000000.0	USD
CY2020Q4	ncbs	Trust Preferred Securities Qualify As Tier1 Capital TrustPreferredSecuritiesQualifyAsTier1Capital	23900000	USD

Files In Submission

Name	View Source	Status
0001174850-21-000029-index-headers.html	Edgar Link	pending
0001174850-21-000029-index.html	Edgar Link	pending
0001174850-21-000029.txt	Edgar Link	pending
0001174850-21-000029-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ncbs-1q21x10qxex311.htm	Edgar Link	pending
ncbs-1q21x10qxex312.htm	Edgar Link	pending
ncbs-1q21x10qxex321.htm	Edgar Link	pending
ncbs-1q21x10qxex322.htm	Edgar Link	pending
ncbs-20210331.htm	Edgar Link	pending
ncbs-20210331.xsd	Edgar Link	pending
ncbs-20210331_cal.xml	Edgar Link	unprocessable
ncbs-20210331_def.xml	Edgar Link	unprocessable
ncbs-20210331_htm.xml	Edgar Link	completed
ncbs-20210331_lab.xml	Edgar Link	unprocessable
ncbs-20210331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NIC
NICOLET BANKSHARES INC Stock $nic

2021 Q1 Form 10-Q Financial Statement

#000117485021000029 Filed on April 30, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NIC NICOLET BANKSHARES INC Stock $nic

2021 Q1 Form 10-Q Financial Statement

#000117485021000029 Filed on April 30, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NIC
NICOLET BANKSHARES INC Stock $nic